Signs Joint Rd Partnership Agreement With Insilico Medicine
22/06/2026 05:58
BRIEF-Sk Biopharmaceuticals Co - Signs Joint Rd Partnership Agreement With Insilico Medicine SK Biopharmaceuticals Co Ltd 326030.KS:
SK BIOPHARMACEUTICALS CO - SIGNS JOINT RD PARTNERSHIP AGREEMENT WITH INSILICO MEDICINE
SK BIOPHARMACEUTICALS CO - JOINT RESEARCH TO DISCOVER CNS NEUROIMMUNE DRUG CANDIDATES USING INSILICO AI PLATFORM
SK BIOPHARMACEUTICALS CO - CONTRACT SIZE UP TO 3.95 TLN WON (USD 2.57 BILLION) PAYABLE TO INSILICO MEDICINE
Source text: [ID:]
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker